Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression...

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• T cell lymphoma is a progressive malignancy.
• Understanding gene expression differences between indolent and aggressive stages is crucial for targeted therapies.

Purpose of the Study:

• To compare gene expression profiles between early and advanced stages of T cell lymphoma.
• To identify differentially expressed genes associated with lymphoma progression.

Main Methods:

• Utilized cDNA microarray to analyze the expression of approximately 8000 genes.
• Compared gene expression between two clonally related T cell lines from different lymphoma stages.
• Validated findings using reverse transcription-polymerase chain reaction and Northern blotting.

Main Results:

• Identified 180 differentially expressed genes (≥5-fold change) between early and advanced T cell lymphoma stages.
• 56 genes were up-regulated and 124 genes were down-regulated in advanced lymphoma cells.
• Up-regulated genes in advanced lymphoma were linked to cell proliferation, survival, and drug resistance; down-regulated genes were associated with cell activation, cell cycle regulation, adhesion, apoptosis, and genome integrity.

Conclusions:

• Differential gene expression patterns correlate with the clinical behavior of T cell lymphoma.
• Identified genes provide potential targets for understanding and treating lymphoma progression.